Chardan lowered the firm’s price target on Femasys to $10 from $12 but keeps a Buy rating on the shares after its Q4 results. The analyst states that the firm’s lower price target reflects a higher projected future share count as modeled future capital raises are expected to be more dilutive due to the current lower share price.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on FEMY: